Lyka Labs share price
You have to be logged in to add this to Watchlist.- ₹72.60(-3.82%)January 23, 2026 15:29:20 PM IST
- NSE
- BSE
- Vol : 11.72 K (NSE + BSE)Last 20 day avg : 27.48 K
Lyka Labs is trading -3.82% lower at Rs 72.60 as compared to its last closing price. Lyka Labs has been trading in the price range of 76.50 & 72.60. Lyka Labs has given -1.11% in this year & -2.55% in the last 5 days. Lyka Labs has TTM P/E ratio 168.55 as compared to the sector P/E of 22.37.The company posted a net profit of -3.36 Crores in its last quarter.Listed peers of Lyka Labs include Torrent Pharmaceuticals (-2.48%), Sun Pharmaceutical Industries (-0.24%), Divi's Laboratories (-1.08%).The Mutual Fund holding in Lyka Labs was at 0.01% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Lyka Labs was at 0.17% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 25, 2026, 06:37 AM UTC
- BetaMedium volatility0.88Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.38The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-2.92The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Neutral | 3,924.15 | -2.48 | 1,32,927.95 | 67.32 | 17.1 | 0.83 | 17.62 |
| Sun Pharmaceutical Industries | Bearish | 1,630.45 | -0.24 | 3,91,070.72 | 36.24 | 5.77 | 0.92 | 0.50 |
| Divi's Laboratories | Bearish | 6,007.00 | -1.08 | 1,59,244.08 | 78.61 | 11.52 | 0.46 | 0.01 |
| Cipla | Bearish | 1,314.85 | -4.13 | 1,06,175.04 | 22.95 | 3.87 | 0.87 | 0.81 |
| Dr Reddy's Laboratories | Neutral | 1,235.15 | 1.48 | 1,03,084.54 | 18.63 | 3.14 | 0.63 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-29 | Quarterly Results |
| 2025-11-12 | Quarterly Results & Others |
| 2025-09-29 | Others |
| 2025-08-01 | Quarterly Results |
| 2025-05-26 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE933A01014
- BSE Code500259
- NSE CodeLYKALABS
Lyka Labs is trading at 72.60 as on Fri Jan 23 2026 09:59:20. This is -3.82% lower as compared to its previous closing price of 75.48.
The market capitalization of Lyka Labs is 259.18 Cr as on Fri Jan 23 2026 09:59:20.
The 52 wk high for Lyka Labs is 163.55 whereas the 52 wk low is 71.99
Lyka Labs can be analyzed on the following key metrics -
- TTM P/E: 168.55
- Sector P/E: 22.37
- Dividend Yield: 0.00%
- D/E ratio: 0.31
Lyka Labs reported a net profit of 8.01 Cr in 2025.
The Mutual Fund Shareholding was 0.01% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
Lyka Labs QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.